Not available outside of the UK & Ireland.
General description
Desmethylolanzapine is the primary metabolite of olanzapine, marketed as the atypical antipsychotic Zyprexa®for the treatment of schizophrenia and bipolar disorder. This new certified solution standard is suitable for use in LC or GC applications including clinical toxicology analysis, forensic testing, or therapeutic drug monitoring.
Legal Information
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
CERILLIANT is a registered trademark of Cerilliant Corporation
Zyprexa is a registered trademark of Eli Lilly and Co.
This product has met the following criteria to qualify for the following awards: